Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed2
Recruiting3

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT06871228Not ApplicableRecruiting
Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation
Atrial Fibrillation (AF)
PrincipalinvestigatorStart date: 2025-08-05
NCT06883864Not ApplicableRecruiting
Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial
Atrial Fibrillation (AF)Atrial Functional Mitral RegurgitationCatheter Ablation
PrincipalinvestigatorStart date: 2025-04-08
NCT05238012Phase 4Completed
Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes
Metabolism Disorder, GlucoseMetabolism Disorder, Lipid
PrincipalinvestigatorStart date: 2022-08-02
NCT04497376Not ApplicableCompleted
Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation
Catheter AblationPersistent Atrial Fibrillation
PrincipalinvestigatorStart date: 2021-08-27
NCT06987825Recruiting
Chinese Atrial Fibrillation Registry
Atrial Fibrillation (AF)
PrincipalinvestigatorStart date: 2011-08-01

Research Network

Collaboration Network

45 collaborators·47 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Caihua Sang, MD

Beijing Anzhen Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Catheter AblationAtrial FibrillationAtrial Functional Mitral Regurgitation+1 more

Worked with same sponsors:

AbbottBeijing Anzhen Hospital+4 more
Collaborated on 2 trials
Similarity Score48%

Chenyang Jiang, MD

Sir Run Run Shaw Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Atrial FibrillationCatheter AblationPersistent Atrial Fibrillation

Worked with same sponsors:

Beijing Anzhen HospitalFukuoka University+3 more
Collaborated on 1 trial
Similarity Score34%

Jianzeng Dong, MD

Beijing Anzhen Hospital; The First Affiliated Hospital of Zhengzhou University

Related
1 trials

Shared therapeutic areas:

Catheter AblationPersistent Atrial Fibrillation

Worked with same sponsors:

Beijing Anzhen HospitalFukuoka University+3 more
Collaborated on 1 trial
Similarity Score24%

Vivek Reddy, MD

Icahn School of Medicine at Mount Sinai

Related
28 trials

Shared therapeutic areas:

Atrial FibrillationPersistent Atrial FibrillationCatheter Ablation
Similarity Score15%

Caihua Sang

Beijing Anzhen Hospital

Related
2 trials

Shared therapeutic areas:

Atrial Fibrillation

Worked with same sponsors:

Beijing Anzhen Hospital
Collaborated on 1 trial
Similarity Score14%

Dhanunjaya Lakkireddy, MD

Kansas City Heart Rhythm Institute

Related
15 trials

Shared therapeutic areas:

Atrial FibrillationPersistent Atrial Fibrillation
Similarity Score10%

Andrea Natale, MD

Texas Cardiac Arrhythmia Research Foundation

Related
18 trials

Shared therapeutic areas:

Atrial FibrillationPersistent Atrial Fibrillation
Similarity Score10%

catherine GEINDRE

Assistance Publique Hopitaux De Marseille

Related
13 trials

Shared therapeutic areas:

Atrial Fibrillation
Similarity Score5%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Atrial Fibrillation
Similarity Score5%

Robert Fishel, MD

JFK Medical Center

Related
3 trials

Shared therapeutic areas:

Atrial Fibrillation
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06871228Not ApplicablePrincipalInvestigator

Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation

Atrial Fibrillation (AF)
Recruiting
NCT06883864Not ApplicablePrincipalInvestigator

Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial

Atrial Fibrillation (AF)Atrial Functional Mitral RegurgitationCatheter Ablation
Recruiting
NCT05238012Phase 4PrincipalInvestigator

Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes

Metabolism Disorder, GlucoseMetabolism Disorder, Lipid
Completed
NCT04497376Not ApplicablePrincipalInvestigator

Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation

Catheter AblationPersistent Atrial Fibrillation
Completed
NCT06987825PrincipalInvestigator

Chinese Atrial Fibrillation Registry

Atrial Fibrillation (AF)
Recruiting

All 5 trials loaded